Know Cancer

or
forgot password

Taking Herbal Formula:DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients in Late-stage:A Clinical Control Trial Study


Phase 2
20 Years
80 Years
Open (Enrolling)
Both
Non-organic Loss of Appetite

Thank you

Trial Information

Taking Herbal Formula:DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients in Late-stage:A Clinical Control Trial Study


Intervention group

- 1. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed
and separated into four packages;

- 2. each package was given to each patient four times a day (three time after meal and
one time before sleep);

- 3. each patient received the usual medication of the hospice ward at the same time;

- 4. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st
day, the 3rd day and the 6th day;

- 5. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative
Oncology Group Performance Status) at the 1st day and the 6th day.

Control group

- 1. each patient received the usual medication of the hospice ward during the trial
interval;

- 2. record the patients' score of receive pre-test, mid-test and after-test of QIPCTP at
the 1st day, the 3rd day and the 6th day;

- 3. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative
Oncology Group Performance Status) at at the 1st day and the 6th day.

Medicine DaHuang herbal abstract powder is produced by Sun Ten Pharmaceutical Co., Ltd, and
it's product serial number: 276001. GanCao herbal abstract powder is also produced by Sun
Ten Pharmaceutical Co., Ltd, and it's product serial number: 185645. Each herbal abstract
powder is qualified with the data of HPLC to confirm each content and stability. The
pharmaceutical company is qualified by Good Manufacturing Practice (GMP) certification in
Taiwan.


Inclusion Criteria:



- Terminal cancer patients in hospice ward

- Patients with appetite loss condition

- Ages between 20 to 80 years old

- No history of diabetes

Exclusion Criteria:

- Entered the stage of dying patients

- Receiving other traditional Chinese medicine

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care

Outcome Measure:

appetite score

Outcome Description:

The investigators detect the patients' appetite condition at the 1st,3rd and 6th day.

Outcome Time Frame:

6 days

Safety Issue:

Yes

Principal Investigator

Yu De LIU, Master

Investigator Role:

Study Chair

Investigator Affiliation:

Changhua Christian Hospital

Authority:

Taiwan: Department of Health

Study ID:

100610

NCT ID:

NCT01503346

Start Date:

March 2011

Completion Date:

March 2012

Related Keywords:

  • Non-organic Loss of Appetite
  • Appetite Loss
  • Anorexia

Name

Location